InsidersTradesSigma
Follow the AMAG PHARMACEUTICALS INC. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €1,899.2bn. The latest transaction was disclosed on 5 January 2016 (Attribution). Among the most active insiders: Grund Nicholas. Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
AMAG Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of treatments for women's health and chronic diseases. It is listed on NASDAQ under the symbol AMAG.